Su Zhen
Directeur/Membre du Conseil chez KARYOPHARM THERAPEUTICS INC.
Profil
Su Zhen is currently the Chief Executive Officer & Director at Marengo Therapeutics, Inc., an Independent Director at Karyopharm Therapeutics, Inc., and an Independent Director at CytomX Therapeutics, Inc. Previously, Dr. Zhen held the position of SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021 and Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019.
Dr. Zhen holds an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
Postes actifs de Su Zhen
| Sociétés | Poste | Début |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Directeur/Membre du Conseil | 31/08/2023 |
| CYTOMX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/03/2024 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Directeur Général | 01/07/2021 |
Anciens postes connus de Su Zhen
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Directeur Technique/Scientifique/R&D | 01/01/2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Directeur Technique/Scientifique/R&D | 01/01/2019 |
Formation de Su Zhen
| Dresden University of Technology | Doctorate Degree |
| University of Toronto | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| MERCK KGAA | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
